131 related articles for article (PubMed ID: 35797545)
21. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
23. [Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer].
Yao W; Lu N; Cui M; Wang J; Du Z; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):837-842. PubMed ID: 32895212
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.
Yang Y; Zheng J; Li Y
Eur J Surg Oncol; 2022 May; 48(5):1017-1024. PubMed ID: 34876328
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of metastatic lymph node number and ratio in oesophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation.
Chien HC; Chen HS; Wu SC; Hsu PK; Liu CY; Wang BY; Shih CH; Liu CC
Eur J Cardiothorac Surg; 2016 Aug; 50(2):337-43. PubMed ID: 26893382
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of methodologies for predicting overall survival in patients with non-small cell lung cancer based on the number and rate of resected positive lymph nodes: A study based on the SEER database for 2010 through 2019.
Guo Q; Hu S; Wang S; Su L; Zhang W; Xu J; Wei Y
Clin Respir J; 2023 Nov; 17(11):1145-1157. PubMed ID: 37723579
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
Zheng W; Jiang W; Wu Q; Chen J; Zhang Z; Yu S; Guo C
BMJ Open; 2023 Apr; 13(4):e068044. PubMed ID: 37185648
[TBL] [Abstract][Full Text] [Related]
29. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
30. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Depypere L; De Hertogh G; Moons J; Provoost AL; Lerut T; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Ann Thorac Surg; 2021 Dec; 112(6):1847-1854. PubMed ID: 33352178
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study.
Yuan Y; Ma G; Hu X; Huang Q
Cancer Med; 2020 Jul; 9(13):4648-4655. PubMed ID: 32391623
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.
Kim SH; Jung KH; Kim TY; Im SA; Choi IS; Chae YS; Baek SK; Kang SY; Park S; Park IH; Lee KS; Choi YJ; Lee S; Sohn JH; Park YH; Im YH; Ahn JH; Kim SB; Kim JH
Cancer Res Treat; 2016 Oct; 48(4):1373-1381. PubMed ID: 27034147
[TBL] [Abstract][Full Text] [Related]
33. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?
Tan Z; Ma G; Yang H; Zhang L; Rong T; Lin P
J Thorac Oncol; 2014 Aug; 9(8):1214-21. PubMed ID: 25157776
[TBL] [Abstract][Full Text] [Related]
34. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.
Jian-Hui C; Shi-Rong C; Hui W; Si-le C; Jian-Bo X; Er-Tao Z; Chuang-Qi C; Yu-Long H
Tumour Biol; 2016 Aug; 37(8):11105-13. PubMed ID: 26912060
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of lymph node ratio in resectable rectal cancer after preoperative short-course radiotherapy-results from randomized clinical trial.
Pach R; Szczepanik AM; Sierzega M; Daniluk M; Richter P
Langenbecks Arch Surg; 2022 Nov; 407(7):2969-2980. PubMed ID: 35788774
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Four Lymph Node Staging Systems in Gastric Adenocarcinoma after Neoadjuvant Therapy - A Population-Based Study.
Lai H; Zheng J; Li Y
Front Surg; 2022; 9():918198. PubMed ID: 35756471
[TBL] [Abstract][Full Text] [Related]
38. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
